Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PHF24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OFCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MRPL57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102467079 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ENG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928269 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4800 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RAPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BPHL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on